Integrated hepatitis B virus (HBV) DNA is almost invariably found in hepatocellular carcinomas (HCC) which develop in HBV carriers. Integrated HBV DNAs from two single-integration HCCs (C3 and C4) have been cloned, and the cellular integration sites have been analyzed. Integrated HBV DNA of C3 is present in chromosome 6 and contains a nearly complete linear HBV genome. The HBV DNA integration in tumor C3 was not associated with major rearrangements of cellular DNA. In contrast, the integrated HBV DNA in C4 contains a large inverted repeat of HBV DNA, in which each repeat consists of a linear HBV DNA segment similar to that present in C3. The C4 integration was also accompanied by a cellular DNA translocation at the HBV integration site. The translocation occurred between chromosomes 17 and 18, along with a deletion of at least 1. HCC (2, 5, 8) . This is consistent with their potential action as tumor initiators (9) . Hepadnaviruses so far have not been shown to contain a viral oncogene per se, nor has a common cellular integration site been identified in HCCs (7, (10) (11) (12) . In addition, some human and woodchuck HCCs from carriers do not contain any integrated or free viral DNA (6, 7, 13). These findings raise the possibility that viral antigens are not required for the maintenance of HCC and may function only as tumor initiators. Additional studies are necessary to identify a unifying molecular mechanism to explain the strong epidemiological data linking chronic infection with HCC.
grated HBV DNA of C3 is present in chromosome 6 and contains a nearly complete linear HBV genome. The HBV DNA integration in tumor C3 was not associated with major rearrangements of cellular DNA. In contrast, the integrated HBV DNA in C4 contains a large inverted repeat of HBV DNA, in which each repeat consists of a linear HBV DNA segment similar to that present in C3. The C4 integration was also accompanied by a cellular DNA translocation at the HBV integration site. The translocation occurred between chromosomes 17 and 18, along with a deletion of at least 1.3 kilobases of chromosome 18 DNA at the translocation site. Our data support a model in which postintegration rearrangement of integrated HBV and cellular DNA results in the generation of chromosomal aberrations. These chromosomal aberrations may function in a multistage mechanism leading to fully malignant HCC.
Epidemiologic studies have revealed a strong correlation between the occurrence of hepatocellular carcinoma (HCC) and endemic hepatitis B virus (HBV) infection in human populations worldwide. Specifically, chronic HBV surface antigen (HBsAg)-positive carriers have up to 200-fold greater risk of developing HCC than uninfected individuals from the same area (1) . The discovery that host DNA from most primary HCCs contained integrated HBV DNA stimulated interest in the possible role of viral DNA integration in hepatocarcinogenesis (2) (3) (4) (5) (6) (7) . Both HBV and the closely related woodchuck hepatitis virus (WHV) can integrate into cellular DNA during chronic infection, preceding HCC (2, 5, 8) . This is consistent with their potential action as tumor initiators (9) . Hepadnaviruses so far have not been shown to contain a viral oncogene per se, nor has a common cellular integration site been identified in HCCs (7, (10) (11) (12) . In addition, some human and woodchuck HCCs from carriers do not contain any integrated or free viral DNA (6, 7, 13) . These findings raise the possibility that viral antigens are not required for the maintenance of HCC and may function only as tumor initiators. Additional studies are necessary to identify a unifying molecular mechanism to explain the strong epidemiological data linking chronic infection with HCC.
Factors that stimulate the incidence of chromosome aberrations are associated with increased risk of neoplasia (9, 14) . In the case of chemical hepatocarcinogenesis in the mouse and rat, agents that damage DNA stimulate the occurrence of HCC (15) (16) (17) (18) . The ability of oncogenic viruses to damage DNA through integration and by increasing the mutation rate of cellular genes is probably an important factor in virusmediated multistage carcinogenesis (19) . To investigate the possible role of HBV integrations in a general mechanism involving host DNA rearrangements, we have studied the structure of cellular DNA sequences at HBV integration sites. A previous study (20) reported a large deletion of cellular DNA at chromosome position 11p13 in association with an HBV integration. In this report we describe an HBV-induced translocation between chromosomes 17 and 18. We believe it is the first translocation to be directly linked to any viral DNA integration. The ability of HBV integrations to generate chromosome defects may be part of a multistep mechanism in the development of fully malignant HCC.
METHODS
Primary HCCs were obtained from two HBV carriers at autopsy. The first tumor, C3, was obtained from a 62-year-old Japanese man and the second, C4, was obtained from a 37-year-old Japanese man. Both were HBsAg-positive, and both tumors had a trabecular phenotype.
DNA was extracted from the tumors, and restriction endonuclease fragments containing integrated HBV DNA were identified by Southern blot analysis as previously reported (3) . Tumors C3 and C4 each contained only a single site of HBV integration. HindIII-digested tumor DNAs were size-fractionated and specific size fractions were ligated into HindIII arms of X phage Charon 30 and packaged in vitro (3, 21) . The recombinant phage library was screened with purified 32P-labeled HBV probe as described (3) , and positive clones were plaque-purified and designated clones C3 and C4 accordingly.
Restriction endonuclease maps of the clones in this report were determined by Southern blot analysis. Restriction fragments from clones C3 and C4 corresponding to unique cellular flanking sequences were isolated and used as probes in genomic-mapping studies. The restriction fragments used as probes are denoted by brackets below the restriction maps of integrated HBV DNA in Figs. 2 
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were identical in structure to the integrated HBV DNA present in the original tumors. Restriction endonuclease maps of clones C3 and C4 were determined by Southern blotting with 32P-labeled HBV probe (Fig. 1) . The structural organization of integrated HBV DNA was determined according to the known restriction map of the HBV genome. The restriction map of the integrated sequences was similar to that of HBV clones of the Adr subtype, which is common in Japan (22) . Electron microscopic heteroduplex analysis of the purified inserts with cloned HBV DNA confirmed the restriction endonuclease maps (data not shown).
Both viral-cellular junctions of the C3 integration were in the cohesive overlap region of the HBV genome. The cohesive overlap is defined by a pair of 11-bp direct repeats, designated DRI and DRII, which are located at nucleotides 1824 and 1590, respectively, on the circular HBV genome map (Fig. lc) . The integrated DNA in clone C3 is a nearly unit-length HBV genome. Clone C4 contains 6.0 kb of integrated HBV DNA comprised of two =3.0-kb segments in inverted orientation (Fig. lb) . Each 3.0-kb repeat is colinear with the HBV genome, and the viral-cellular DNA junctions are also in the cohesive overlap region. The inversion occurred at the 5' end of the core antigen (HBcAg) gene. Each 3.0-kb segment of HBV in C4 closely resembles the linear HBV DNA present in clone C3. Since all four of the viral-cellularjunctions in clones C3 and C4 are located in the cohesive overlap of HBV, a specific integration mechanism is implicated (see Discussion).
C3 HBV Integration Site. Restriction endonuclease fragments containing unique cellular DNA were isolated from the left and right flanking sequences of clones C3 and C4 and these were used to probe Southern blots of leukocyte and tumor DNAs. Southern blots of leukocyte DNA hybridized with the left and right flanking probes from clone C3 showed that both probes hybridized to common-size HindIll, EcoRI, and BamHI genomic DNA fragments (Fig. 2) . The 1.6-kb HindIII fragment that hybridized to both probes was the length ofthe cellular sequences in clone C3, as determined by subtracting the length of integrated HBV DNA (3.1 kb) from the total length of the clone (4.7 kb) (Fig. 2 ). This indicated that rearrangement of cellular sequences had not occurred during HBV integration. This conclusion was also supported by Bgl II digestion data. The left-hand probe hybridized to a 1.1-kb HindIII-Bgl II fragment in leukocyte DNA that was the expected size for a HindIII-Bgl II fragment spanning the HBV integration site.
C4 HBV Integration Site. Since Bgi II and HindIII did not cut cellular sequences within clone C4, we expected that the probes from the right-and left-hand cellular DNA should hybridize to common-size Bgi II and HindIII fragments in normal DNA if no rearrangement of cellular sequences had occurred at the HBV integration site. However, hybridization of the C4 left and right flanking probes with leukocyte DNA revealed hybridization to different-size restriction endonuclease fragments, leading to the conclusion that the sequences were not contiguous in normal DNA (Fig. 3 Upper). The restriction map of clone C4, in combination with Southern blot data of leukocyte DNA, allowed us to construct restriction maps ofthe normal cellular loci homologous to the right and left flanking probes (Fig. 3 18N , which is the normal right-hand locus spanning the HBV integration site. The hash-marked region is the 2.5-kb Xba I fragment used as a probe for chromosome 18 sequences in tumor C4 (Fig. 4) . Restriction endonuclease abbreviations are as in Fig. 1 (Fig. 3 Lower, line 3 bracket) . The only DNA segment of this clone that did not contain highly repeated DNA sequences was the 2.5-kb Xba I fragment that spanned the breakpoint on chromosome 18 ( Fig. 3 Lower, line 3 hatch marks). This DNA fragment was isolated and used as a hybridization probe to test whether reciprocal recombination had occurred during the translocation event. We predicted that, if reciprocal recombination had occurred, we would observe three DNA fragments hybridizing to the 18N probe when it was hybridized to C4 tumor DNA. These fragments would correspond to (i) the right-hand normal sequence, (ii) the C4 right-hand HBV junction fragment (chromosome 18), and (iii) the predicted chromosome 17-18 reciprocal recombination fusion fragment comprising sequences to the left of the chromosome 18 breakpoint and to the right of the chromosome 17 breakpoint.
Hybridization of the 18N probe to C4 tumor and normal cellular DNAs revealed the presence of only two fragments, which corresponded to (i) the right-hand HBV junction fragment and (ii) the normal allele (Fig. 4) . We could not detect the third predicted reciprocal recombination fusion fragment in any of the digests we tested. This was particularly evident for the Sph I digest of C4 tumor DNA, in which the normal 8.5-kb fragment and the 1.9-kb HBV junction fragment were identified but the proposed recombination fragment of 9.4 kb was not observed (Fig. 4) . We therefore concluded that a deletion of -1.3 kb ofcellular DNA (through the Xba I site to the left of the chromosome 18 breakpoint) had occurred before or during the initial HBV integration or during the translocation event. The deleted sequences must have been lost from the tumor cell, otherwise a third fragment would have been observed in our experiment.
DISCUSSION
The HBV viral-cellular and viral-viral junctions in clones C3 and C4 have been located in the cohesive overlap of the HBV genome by restriction endonuclease and heteroduplex analysis. In the case of integration C3, an almost complete linear HBV genome is present, with one viral-cellular DNA junction near the 5' end of the HBcAg gene and the other near the 3' end of the X gene of HBV. This structure may have resulted from the integration of a viral replication intermediate that had completed minus-strand DNA synthesis. Minus-strand DNA replication intermediates contain a protein primer at their 5' end (36) . Cleavage of the protein primer plus a small segment of the virion DNA from the 5' end of a DNA minus strand during integration would produce at least one viral-cellular junction in the cohesive overlap region of HBV. If a complete minus strand served as the source for integrated DNA, the other viral-cellularjunction should be in the DRI sequence of HBV. DNA sequencing has shown that this is the case (data not shown). An integration mechanism involving replication intermediates has been proposed (26) and predicts the absence ofterminal duplication of sequences in the cohesive overlap region in any single linear HBV integration, as was observed for integration C3.
Integrated HBV DNA in clone C4 resembles an inverted repeat of HBV DNA sequences present in clone C3. This leads to the hypothesis that the inverted duplication was generated by recombination between two initially separate integrated tNAs on separate chromosomes. We investigated the mechanism by which the C4 translocation was generated by cloning the normal DNA across the chromosome 18 breakpoint. If The human-mouse hybrid cell panel was derived from independent sets of hybrids constructed with 4 mouse cell lines and 12 human fibroblast lines (23, 24) . Chromosomes of hybrid cells were karyotyped and banded by Giemsa/trypsin staining (25); "t" indicates that a translocated piece of a chromosome was present, but not the intact chromosome. Enzyme markers assigned to each chromosome except Y have been tested on each cell hybrid (24) to confirm the chrtmosome analysis. Chromosomes, enzymes, and the probes were tested on the same cell passage for each hybrid. Most hybrids were derived from karyotypically normal human parental cells; the others were derived from parental cells with well-defined translocation chromosomes for regional chromosome mapping. All three probes were hybridized simultaneously to Southern blots ofBgl II-digested DNA from each cell hybrid; scoring indicates the presence (+) or absence (-) of human bands on the blots. Discordant hybrids either retained the sequences but not a specific chromosome or vice versa.
we used normal DNA across the chromosome 18 breakpoint as a hybridization probe of C4 tumor DNA. We were not able to detect the extra restriction fragments homologous to the second reciprocal recombination chromosome that were predicted. This suggested that a deletion of host DNA sequences had also occurred in addition to the translocation.
The deletion must have encompassed at least 1.3 kb of DNA immediately to the left of the breakpoint on chromosome 18, otherwise our probe would have detected an additional restriction fragment.
The deletion of host DNA sequences, in association with a chromosomal translocation, has been reported for a translocation of the c-myc gene to the immunoglobulin locus in a murine plasmacytoma (27) . Also, integrated HBV and WHV DNAs from human and woodchuck HCCs most often have undergone multiple rearrangements of viral sequences, including deletions and direct or inverted duplications (3, 10, 11, 21, 28, 29 esis, in general, suggests that they play a role in a multistep mechanism leading to fully malignant HCC. across the HBV inversion in clone C4 (data not shown) show that the translocation was not generated by homologous recombination between separate integrated HBV DNAS and that another mechanism, possibly involving a breakage and reunion event, probably generated the translocation.
The absence of integrated HBV DNA in some tumors shows that HBV gene products are most likely not required for the maintenance of HCC. Therefore, if the virus functions as a tumor initiator, it is most probably one that may be lost from the cell after initiation has occurred. This would be similar to mechanisms proposed for several persistent DNA viruses that can cause cellular DNA rearrangements by a "hit-and-run" mechanism (30, 31) . In one report (32) , three cell lines transformed with adenovirus type 12 showed loss of all integrated viral DNA. These cells maintained their oncogenic phenotype, but they reverted from an epithelial morphology to a fibroblastic morphology. A related hit-andrun mechanism is probably responsible for herpes simplex virus transformation. All human herpesviruses induce chromosomal aberrations (19, 33) and recent work has shown that the transforming sequences of herpes simplex virus types 1 and 2 and of cytomegalovirus contain DNA sequences with structural characteristics similar to insertion-sequence elements (34) . Restriction enzymes that cut within these elements destroy the transformation activity, possibly by preventing their action as insertion sequences.
In general, once HCC cell lines are established, the HBV integration pattern is quite stable. However, amplification and transposition of integrated HBV plus flanking cellular sequences has been reported in the PLC/PRF/5 hepatoma cell line (28, 35) . Whether this transposition occurred in the primary tumor or during establishment of the cell line is unknown. Mizusawa et al. (29) have also reported the inverted duplication of HBV and cellular sequences cloned from a human hepatoma cell line. The translocation in this report and an earlier report (20) of deletion of cellular DNA associated with HBV integration show that HBV integrations may serve as focal points for the generation of chromosomal aberrations present in primary HCC. The specific function of these aberrations is not understood. However, the welldocumented role of chromosomal aberrations in carcinogen-
